Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.

Vasculogenic mimicry (VM) is a newly-defined tumor microcirculation pattern in highly aggressive malignant tumors. We recently reported tumor growth and VM formation of gallbladder cancers through the contribution of the ephrin type a receptor 2 (EphA2)/focal adhesion kinase (FAK)/Paxillin signaling...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hui Wang, Wei Sun, Wen-Zhong Zhang, Chun-Yan Ge, Jing-Tao Zhang, Zhong-Yan Liu, Yue-Zu Fan
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2014
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/01986b242346422795eb59d716660701
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:01986b242346422795eb59d716660701
record_format	dspace
spelling	oai:doaj.org-article:01986b242346422795eb59d7166607012021-11-18T08:20:04ZInhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.1932-620310.1371/journal.pone.0096982https://doaj.org/article/01986b242346422795eb59d7166607012014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24811250/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Vasculogenic mimicry (VM) is a newly-defined tumor microcirculation pattern in highly aggressive malignant tumors. We recently reported tumor growth and VM formation of gallbladder cancers through the contribution of the ephrin type a receptor 2 (EphA2)/focal adhesion kinase (FAK)/Paxillin signaling pathways. In this study, we further investigated the anti-VM activity of norcantharidin (NCTD) as a VM inhibitor for gallbladder cancers and the underlying mechanisms. In vivo and in vitro experiments to determine the effects of NCTD on tumor growth, host survival, VM formation of GBC-SD nude mouse xenografts, and vasculogenic-like networks, malignant phenotypes i.e., proliferation, apoptosis, invasion and migration of GBC-SD cells. Expression of VM signaling-related markers EphA2, FAK and Paxillin in vivo and in vitro were examined by immunofluorescence, western blotting and real-time polymerase chain reaction (RT-PCR), respectively. The results showed that after treatment with NCTD, GBC-SD cells were unable to form VM structures when injecting into nude mouse, growth of the xenograft was inhibited and these observations were confirmed by facts that VM formation by three-dimensional (3-D) matrix, proliferation, apoptosis, invasion, migration of GBC-SD cells were affected; and survival time of the xenograft mice was prolonged. Furthermore, expression of EphA2, FAK and Paxillin proteins/mRNAs of the xenografts was downregulated. Thus, we concluded that NCTD has potential anti-VM activity against human gallbladder cancers; one of the underlying mechanisms may be via blocking the EphA2/FAK/Paxillin signaling pathway.Hui WangWei SunWen-Zhong ZhangChun-Yan GeJing-Tao ZhangZhong-Yan LiuYue-Zu FanPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 5, p e96982 (2014)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Hui Wang Wei Sun Wen-Zhong Zhang Chun-Yan Ge Jing-Tao Zhang Zhong-Yan Liu Yue-Zu Fan Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
description	Vasculogenic mimicry (VM) is a newly-defined tumor microcirculation pattern in highly aggressive malignant tumors. We recently reported tumor growth and VM formation of gallbladder cancers through the contribution of the ephrin type a receptor 2 (EphA2)/focal adhesion kinase (FAK)/Paxillin signaling pathways. In this study, we further investigated the anti-VM activity of norcantharidin (NCTD) as a VM inhibitor for gallbladder cancers and the underlying mechanisms. In vivo and in vitro experiments to determine the effects of NCTD on tumor growth, host survival, VM formation of GBC-SD nude mouse xenografts, and vasculogenic-like networks, malignant phenotypes i.e., proliferation, apoptosis, invasion and migration of GBC-SD cells. Expression of VM signaling-related markers EphA2, FAK and Paxillin in vivo and in vitro were examined by immunofluorescence, western blotting and real-time polymerase chain reaction (RT-PCR), respectively. The results showed that after treatment with NCTD, GBC-SD cells were unable to form VM structures when injecting into nude mouse, growth of the xenograft was inhibited and these observations were confirmed by facts that VM formation by three-dimensional (3-D) matrix, proliferation, apoptosis, invasion, migration of GBC-SD cells were affected; and survival time of the xenograft mice was prolonged. Furthermore, expression of EphA2, FAK and Paxillin proteins/mRNAs of the xenografts was downregulated. Thus, we concluded that NCTD has potential anti-VM activity against human gallbladder cancers; one of the underlying mechanisms may be via blocking the EphA2/FAK/Paxillin signaling pathway.
format	article
author	Hui Wang Wei Sun Wen-Zhong Zhang Chun-Yan Ge Jing-Tao Zhang Zhong-Yan Liu Yue-Zu Fan
author_facet	Hui Wang Wei Sun Wen-Zhong Zhang Chun-Yan Ge Jing-Tao Zhang Zhong-Yan Liu Yue-Zu Fan
author_sort	Hui Wang
title	Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
title_short	Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
title_full	Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
title_fullStr	Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
title_full_unstemmed	Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
title_sort	inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
publisher	Public Library of Science (PLoS)
publishDate	2014
url	https://doaj.org/article/01986b242346422795eb59d716660701
work_keys_str_mv	AT huiwang inhibitionoftumorvasculogenicmimicryandprolongationofhostsurvivalinhighlyaggressivegallbladdercancersbynorcantharidinviablockingtheephrintypeareceptor2focaladhesionkinasepaxillinsignalingpathway AT weisun inhibitionoftumorvasculogenicmimicryandprolongationofhostsurvivalinhighlyaggressivegallbladdercancersbynorcantharidinviablockingtheephrintypeareceptor2focaladhesionkinasepaxillinsignalingpathway AT wenzhongzhang inhibitionoftumorvasculogenicmimicryandprolongationofhostsurvivalinhighlyaggressivegallbladdercancersbynorcantharidinviablockingtheephrintypeareceptor2focaladhesionkinasepaxillinsignalingpathway AT chunyange inhibitionoftumorvasculogenicmimicryandprolongationofhostsurvivalinhighlyaggressivegallbladdercancersbynorcantharidinviablockingtheephrintypeareceptor2focaladhesionkinasepaxillinsignalingpathway AT jingtaozhang inhibitionoftumorvasculogenicmimicryandprolongationofhostsurvivalinhighlyaggressivegallbladdercancersbynorcantharidinviablockingtheephrintypeareceptor2focaladhesionkinasepaxillinsignalingpathway AT zhongyanliu inhibitionoftumorvasculogenicmimicryandprolongationofhostsurvivalinhighlyaggressivegallbladdercancersbynorcantharidinviablockingtheephrintypeareceptor2focaladhesionkinasepaxillinsignalingpathway AT yuezufan inhibitionoftumorvasculogenicmimicryandprolongationofhostsurvivalinhighlyaggressivegallbladdercancersbynorcantharidinviablockingtheephrintypeareceptor2focaladhesionkinasepaxillinsignalingpathway
_version_	1718421902256504832

Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.

Ejemplares similares